Intestinal obstruction and severe bowel motility disorders are among the most dangerous injuries alleged in GLP-1 drug litigation. Some patients who used GLP-1 medications — including Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Trulicity, Saxenda, and Victoza — report severe constipation, bowel shutdown, abdominal distension, emergency hospitalization, and sometimes surgery.
This page explains intestinal obstruction, how it appears in GLP-1 injury claims, which medical findings matter most in case evaluations, and who may qualify for compensation.
What Is an Intestinal Obstruction?
An intestinal obstruction occurs when the intestines become partially or completely blocked. This can prevent food, liquid, and gas from passing normally. Obstructions can be:
- mechanical (a physical blockage)
- functional (severe motility failure, sometimes called ileus or pseudo-obstruction)
In legal reviews involving GLP-1 drugs, cases often focus on whether drug-induced slowing of GI motilitycontributed to severe constipation, stasis, and obstruction-like events.
GLP-1 Drugs Commonly Named in Obstruction Claims
Intestinal obstruction claim reviews may involve:
Symptoms Commonly Reported in GLP-1 Intestinal Obstruction Cases
Core symptoms
- inability to pass stool
- inability to pass gas
- severe constipation that worsens
- abdominal swelling/distension
- cramping or waves of pain
- nausea and vomiting
Severe warning signs
- vomiting (sometimes feculent)
- dehydration and electrolyte imbalance
- fever or severe tenderness
- fainting or confusion
- hospitalization or emergency imaging
- surgery evaluation
These cases are frequently medically urgent and often involve emergency department care.
How Intestinal Obstruction Is Diagnosed (Key for Eligibility)
Objective medical documentation is critical. Common evidence includes:
Imaging
- CT scan (often most definitive)
- abdominal x-ray
- ultrasound (sometimes supportive)
Hospital Records
- ER notes documenting bowel shutdown
- diagnosis codes and discharge summaries
- surgical consult documentation
- bowel rest or decompression records (e.g., NG tube)
Labs
- dehydration markers
- electrolyte imbalance
- inflammatory markers (when severe)
➡️ Evidence guide: Medical Records
Why These Claims Often Overlap With Other GLP-1 Injuries
Obstruction and bowel shutdown cases frequently overlap with:
- gastroparesis (upper GI paralysis)
- prolonged vomiting and dehydration
- kidney injury from fluid loss
- gallbladder crises during rapid weight loss
Related pages:
Who May Qualify for an Intestinal Obstruction Lawsuit?
You may qualify if:
- you used a GLP-1 drug, AND
- you experienced symptoms consistent with bowel obstruction or severe motility failure, AND
- your condition required medical treatment (especially ER evaluation or hospitalization)
Eligibility is often stronger when you had:
- imaging confirming obstruction or ileus/pseudo-obstruction
- hospital admission for bowel shutdown
- NG tube placement or bowel decompression
- surgery consultation or intervention
- recurrence or persistent motility dysfunction
- long-term dietary restriction or disability
Evidence That Strengthens an Obstruction Case
Strong claim packages often include:
- CT imaging reports
- ER notes describing inability to pass stool/gas
- hospital admission and discharge summaries
- surgical consult notes
- documentation of treatment (bowel rest, NG tube, fluids)
- timeline connecting symptom onset to GLP-1 use or dose escalation
- ongoing GI impairment after the event
➡️ Medical records checklist: Medical Records
Compensation in Intestinal Obstruction Claims
Depending on severity and long-term impact, compensation may address:
- ER and hospitalization costs
- imaging and specialist consultations
- surgical procedures (if performed)
- long-term GI treatment and medications
- lost wages and reduced earning capacity
- disability or ongoing impairment
- pain, suffering, and emotional distress
- diminished quality of life
➡️ More: Compensation
Timeline Factors Often Reviewed
Claim evaluations commonly examine:
- whether symptoms escalated after dose increases
- whether constipation worsened over time
- timing of obstruction relative to GLP-1 therapy
- whether symptoms persisted after discontinuation
- recurrence of obstruction-like events
- ongoing GI motility dysfunction
A documented progression pattern often strengthens causation arguments.
When to Seek Immediate Medical Help
Intestinal obstruction can become life-threatening. Seek emergency care immediately for:
- severe abdominal swelling
- inability to pass gas or stool
- persistent vomiting
- fever
- severe pain with tenderness
- dizziness, fainting, or confusion
- signs of dehydration
How to Start an Intestinal Obstruction Claim Review
To begin, you typically only need:
- GLP-1 drug used and approximate dates
- details of the obstruction event (ER/hospital)
- imaging results (if available)
- treatments received (NG tube, surgery consult, admission)
- whether symptoms continue today
➡️ Start your review: File a Claim
➡️ Criteria: Criteria
Related Internal Links
Intestinal obstruction and severe bowel motility disorders are serious, sometimes life-threatening complications alleged in GLP-1 litigation. Strong cases often involve emergency imaging confirming obstruction or ileus, hospitalization, and intensive treatment. Because these events can overlap with dehydration, kidney injury, and gastroparesis, comprehensive documentation is essential.
If you experienced bowel obstruction or bowel shutdown symptoms after GLP-1 use, you may qualify for a claim review.
➡️ Start your review: File a Claim